Document Detail


Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma.
MedLine Citation:
PMID:  17493574     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To present long-term outcomes of Ahmed glaucoma valve implantation for uveitic glaucoma. DESIGN: Interventional case series. METHODS: Retrospective chart review of 60 patients (60 eyes) with uveitic glaucoma who underwent Ahmed valve implantation over a four-year period at a tertiary uveitis referral center. Success definition 1 included patients with an intraocular pressure (IOP) between 5 and 21 mm Hg, reduced by 25% from that before implantation. Success definition 2 (qualified success) excluded those patients in whom serious complications occurred. RESULTS: Mean follow-up time was 30 months (range, six to 87 months; four-year results relate to a cohort of 15 patients). Success rates were 77% and 50% and qualified success rates were 57% and 39% at one and four years, respectively. At four years, 74% of the patients required glaucoma medication to maintain IOP control. The overall complication rate was 12%/person-years. The rate of visual acuity loss was 4%/person-years; that was most commonly attributed to corneal complications that were more likely to occur in patients with preoperative corneal disease (P = .01, Fisher exact test). CONCLUSIONS: Ahmed glaucoma valve implantation is a safe yet moderately successful procedure for uveitic glaucoma. Long-term success rates are enhanced with the use of glaucoma medications, and corneal complications are the most common of all potential serious complications.
Authors:
Thekla G Papadaki; Ioannis P Zacharopoulos; Louis R Pasquale; William B Christen; Peter A Netland; C Stephen Foster
Related Documents :
24573074 - Clinical and radiographic outcomes after 3-column osteotomies with 5-year follow-up.
3895104 - Late onset endophthalmitis associated with filtering blebs.
17293784 - Management of glaucoma in patients with nanophthalmos.
19384014 - P53 expression in pterygium in two climatic regions in turkey.
12368724 - Technical considerations for late removal of aortic endografts.
16982984 - The evolution of midface rejuvenation: combining the midface-lift and fat transfer.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-05-09
Journal Detail:
Title:  American journal of ophthalmology     Volume:  144     ISSN:  0002-9394     ISO Abbreviation:  Am. J. Ophthalmol.     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-07-02     Completed Date:  2007-07-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370500     Medline TA:  Am J Ophthalmol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  62-69     Citation Subset:  AIM; IM    
Affiliation:
Massachusetts Eye Research and Surgery Institute, Ocular Immunology and Uveitis Foundation, Harvard Medical School Boston, Massachusetts, USA. theklapap@med.uoc.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Child
Female
Follow-Up Studies
Glaucoma / physiopathology,  surgery*
Glaucoma Drainage Implants*
Humans
Intraocular Pressure / physiology
Male
Middle Aged
Postoperative Complications
Prosthesis Implantation
Retrospective Studies
Treatment Outcome
Uveitis / physiopathology,  surgery*
Visual Acuity / physiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Macular schisis and detachment associated with presumed acquired enlarged optic nerve head cups.
Next Document:  A high-throughput assay for the adenylation reaction of bacterial DNA ligase.